Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-29T14:21:53.331Z Has data issue: false hasContentIssue false

Psychopharmacological MRI

Published online by Cambridge University Press:  24 June 2014

Inge Rasmussen Jr*
Affiliation:
Interventional Center, Rikshospitalet University Hospital, Oslo, Norway Department of Psychology, University of Oslo, Oslo, Norway
*
Dr Inge Rasmussen Jr, Interventional Centre, Rikshospitalet University Hospital, Sognsvannsveien 20, 0027 Oslo, Norway. Tel: +47 23070111 Fax: +47 23070110 E-mail: [email protected]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Brain Bytes
Copyright
Copyright © 2010 John Wiley & Sons A/S

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Lagopoulos, J.Functional MRI: an overview. Acta Neuropsychiatr 2007;19: 6465. CrossRefGoogle Scholar
Rasmussen, I Jr, Bjørnerud, A.Perfusion MRI: A brief overview. Acta Neuropsychiatr 2009;21:310311. CrossRefGoogle Scholar
Davis, TL, Kwong, KK, Weisskoff, RM, Rosen, BR.Calibrated functional MRI: mapping the dynamics of oxidative metabolism. Proc Natl Acad Sci USA 1998;95:18341839. CrossRefGoogle ScholarPubMed
Iannetti, GD, Wise, RG.BOLD functional MRI in disease and pharmacological studies: room for improvement? Magn Reson Imaging 2007;25:978988. CrossRefGoogle Scholar
Das, P, Lagopoulos, J.Connectivity. Acta Neuropsychiatr 2009;21:9192. CrossRefGoogle Scholar
Honey, G, Bullmore, E.Human pharmacological MRI. Trends Pharmacol Sci 2004;25:366374. CrossRefGoogle ScholarPubMed
Wilkinson, D, Halligan, P.The relevance of behavioural measures for functionalimaging studies of cognition. Nat Rev Neurosci 2004;5:6773. CrossRefGoogle Scholar